Clinical Trial Update: A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A study evaluating the activity, safety, and tolerability of ZX-101A in advanced solid tumors across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ZX-101A

Snippet

Sponsor: Nanjing Zenshine Pharmaceuticals | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN